Apatinib is an innovative TKI that effectively inhibits VEGFR-2 among various tumor-related kinases (TRKs) and induces apoptosis of VEGFR-2, thereby effectively suppressing the proliferation of multiple tumor cells (Xie et al., 2021; Zhao et al., 2023). The gene discussed is KDR; the disease is neoplasm.